Health Information Services — industry outlook
- Period: 2026-09-28 to 2026-10-19
- Events: 1
- Generated: 2026-10-19T06:30:00.003Z
Cardiometabolic Solution Shift and GLP-1 Value Validation
The industry is pivoting from siloed "point solutions" to multi-condition frameworks addressing cardiometabolic overlaps to defend against rising specialty pharmacy costs, specifically regarding GLP-1 therapies where the market narrative has shifted from coverage feasibility to demonstrating durable outcomes. (OMDA). This strategic transition aims to impact nearly 80% of the care continuum for diabetes and cardiovascular disease, moving away from "vendor" relationships toward "partner" models that prioritize 2–3 year outcome horizons over "365-day" cycles to avoid "snake oil" vendor dynamics. (OMDA).
Primary Care Access Crisis and Population Management Infrastructure
A severe shortage of primary care providers is forcing a redesign of access models, with traditional systems described as "breaking at the seams" and exhibiting wait times of 6–9 months in major markets, necessitating new digital nodes of access. (OMDA). Concurrently, widespread industry adoption of "hyper-segmented" population management remains a lagging practice, with most organizations lacking the infrastructure to target high-cost sub-segments or manage utilization upstream for patients unable to secure continuous care. (OMDA). This gap creates a critical vulnerability where conditions like uncontrolled lipids and blood pressure remain unmanaged due to lack of appointments rather than lack of insurance. (OMDA).
Medicare Reimbursement Dynamics and Commercial Cost Trajectories
Commercial medical cost trends are projected to reach 9% for 2027, creating significant affordability pressure that requires new approaches to bend the cost curve. (OMDA). In the Medicare sector, plans face a convergence of declining government reimbursement, evolving coding paradigms, and a shifting Star rating system, which is exacerbating a trend where providers are increasingly withdrawing from Medicare Advantage populations in favor of commercial work. (OMDA). Despite the urgent need for outcomes-based payment models, current reimbursement structures are characterized as not encouraging for targeted care delivery, with many leaders exhibiting "change aversion" that perpetuates the status quo. (OMDA).